Afficher la notice abrégée

dc.contributor.authorJordan, Bertrand-
dc.date.accessioned2020-12-07T10:25:49Z
dc.date.available2020-12-07T10:25:49Z
dc.date.issued2019
dc.identifier.citationJordan, Bertrand ; Cent ans après, le retour de la phagothérapie ? : Chroniques génomiques, Med Sci (Paris), Vol. 35, N° 10 ; p. 806-809 ; DOI : 10.1051/medsci/2019149
dc.identifier.issn1958-5381
dc.identifier.urihttp://hdl.handle.net/10608/10473
dc.description.abstractBacteriophages were advocated as therapeutic agents more than a century ago, but the advent of antibiotics relegated them to a very minor role. Today, multi-drug resistant bacteria are a serious health problem, and phage therapy enjoys renewed interest. Recent publications show that it can be effective, but also highlight the serious logistic problems involved in using this approach.en
dc.language.isofr
dc.publisherEDP Sciences
dc.relation.ispartofForum
dc.rightsArticle en libre accès - License CC BY 4.0 [http://creativecommons.org/licenses/by/4.0]fr
dc.rightsMédecine/Sciences - Inserm - SRMSfr
dc.sourceM/S. Médecine sciences [ISSN papier : 0767-0974 ; ISSN numérique : 1958-5381], Vol. 35, N° 10; p. 806-809
dc.subject.meshMultirésistance bactérienne aux médicamentsfr
dc.subject.meshHistoire du 20ème sièclefr
dc.subject.meshHistoire du 21ème sièclefr
dc.subject.meshHumainsfr
dc.subject.meshPhagothérapiefr
dc.subject.meshhistoirefr
dc.titleChroniques génomiques - Cent ans après, le retour de la phagothérapie ?fr
dc.title.alternativePhage therapy is back - maybe?en
dc.typeArticle
dc.contributor.affiliationUMR 7268 ADÉS, Aix-Marseille, Université /EFS/CNRS; CoReBio PACA, case 901, Parc scientifique de Luminy, 13288 Marseille Cedex 09, France
dc.identifier.doi10.1051/medsci/2019149
dc.identifier.pmid31625905


Fichier(s) constituant ce document

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée